Loading…
E-commerce fraud-prevention software that guarantees approved online orders against chargebacks for large online retailers.
E-commerce fraud-prevention software that guarantees approved online orders against chargebacks for large online retailers.
Charges a fee on each order it approves and reimburses the merchant if that order later turns out fraudulent (a chargeback, when a card payment is reversed), so it earns when its decisions are right and loses when they are wrong. Revenue rises with the value of orders its customers process. Israel-based, listed since 2021.
Moat: narrow (data, switching costs). Machine-learning fraud models trained on large transaction data are hard to replicate quickly.
Headquarters: Tel Aviv, Israel · Founded: 2013 · Employees: 670
Size Riskified (RSKD) is a United States Information Technology company (Packaged Software) with a market value of $1.13B, the 2175th largest of 3,117 United States companies the cockpit tracks. Shares closed at $8.54 on 6 Nov 2026.
Performance Over six months the shares gained 78.3%, against -10.5% for the median peer and -1.1% for the United States market (cap-weighted) — highest of 20 in its peer set.
Growth Revenue grew 9.6% over the last twelve months (peer median +13.1%); the operating margin is -4.5% (peer median 2.9%).
Valuation It trades at 27.3× forward earnings against a peer median of 24.1× (6th most expensive of 13).
Price implies For today's price to make sense, revenue must grow about 13% a year for seven years (Req g). Recent delivered growth is +15%, so the hurdle is -3 pp: the price already allows for a slowdown.
Short interest Short interest is 1.4% of the free float (15 Oct 2026).
Next results Next results expected around 11 Nov 2026 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $368M | $346M | $327M | $298M | $261M |
| Revenue growth | — | +6% | +10% | +14% | — |
| Gross profit | $186M | $177M | $167M | $151M | $132M |
| EBITDA | -$1.33M | -$7.36M | -$30.3M | -$57.2M | -$93.4M |
| Net income | -$15.6M | -$27.6M | -$34.9M | -$59.0M | -$105M |
| Free cash flow | $49.1M | $33.1M | $39.1M | $5.92M | -$32.4M |
| Capital expenditure | $781,786 | $810,000 | $637,000 | $1.35M | $8.01M |
| Total debt | $23.5M | $25.0M | $27.5M | $31.3M | $37.4M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Riskified RSKD | $1.13B | +78% | +10% | -4% | 27.3× | 12.6% |
| Equifax EFX | $22.2B | +8% | +11% | 19% | 20.9× | 16.9% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | RSKD | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +6.2% | -5.7% | 5th highest of 21 |
| 6-month return | +78.3% | -10.5% | highest of 20 |
| Distance from 52-week high | -7.5% | -38.8% | 2nd highest of 21 |
| Revenue growth (TTM) | +9.6% | +13.1% | 10th lowest of 21 |
| Operating margin | -4.5% | 2.9% | 7th lowest of 21 |
| Forward P/E | 27.3× | 24.1× | 6th most expensive of 13 |
| Growth the price implies (Req g, 7 yrs) | 12.6% | 4.1% | 4th most demanding of 10 |
| Growth delivered (Del g) | +15.3% | +18.9% | 5th lowest of 10 |
| Hurdle (Req g minus delivered) | -2.7 pp | -15.9 pp | 5th most demanding of 10 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Riskified RSKD | United States | $1.13B | +78% | +10% | -4% | 27.3× | 12.6% | +15.3% |
| Red Violet RDVT | United States | $1.12B | +41% | +20% | 18% | 40.3× | 39.4% | +21.1% |
| Hangzhou Diagens Biotechnology 2526.HK | Hong Kong | $1.13B | -68% | +134% | -49% | n/a | n/a | n/a |
| Shanghai Yaoji Technology 002605.SZ | China | $1.14B | -11% | -3% | 20% | 15.0× | 6.4% | +1.0% |
| 74Software 74SW.PA | France | $1.11B | -5% | +11% | 14% | 13.3× | -1.7% | +18.9% |
| Shenzhen Sunline Tech 300348.SZ | China | $1.10B | -22% | +19% | -1% | 84.3× | n/a | n/a |
| Merit Interactive 300766.SZ | China | $1.17B | -30% | +30% | -2% | n/a | n/a | n/a |
| Tansun Technology 300872.SZ | China | $1.08B | -11% | -10% | -12% | 70.3× | n/a | n/a |
| Bingo Software 688227.SS | China | $1.08B | -56% | -7% | -11% | n/a | n/a | n/a |
| Chinasoft International 0354.HK | Hong Kong | $1.18B | 0% | +3% | 2% | 12.4× | 17.8% | +3.1% |
| Blackbuck BLACKBUCK.NS | India | $1.08B | -1% | +50% | 14% | 52.8× | 34.8% | +54.8% |
| ICkey (Shanghai) Internet & Technology 301563.SZ | China | $1.19B | -26% | +26% | 4% | n/a | n/a | n/a |
| BigBear.ai BBAI | United States | $1.07B | -47% | -1% | -66% | n/a | n/a | n/a |
| Beijing Zhongke WengeAI Science and Technology 1956.HK | Hong Kong | $1.19B | n/a | +28% | -54% | n/a | n/a | n/a |
| Bravura Solutions BVS.AX | Australia | $1.06B | +50% | -10% | 25% | 24.3× | 4.1% | +3.1% |
| PATEO CONNECT Technology (Shanghai) 2889.HK | Hong Kong | $1.05B | -65% | +72% | -24% | n/a | n/a | n/a |
| Sichuan Xun You Network Technology 300467.SZ | China | $1.05B | -22% | +2% | 1% | n/a | n/a | n/a |
| Modern Times Group MTG MTG-A.ST | Sweden | $1.22B | +16% | +42% | 11% | 6.6× | -8.4% | +23.7% |
| Vitec Software VIT-B.ST | Sweden | $1.22B | +18% | +6% | 21% | 24.0× | 3.8% | +22.6% |
| InnovAge INNV | United States | $1.22B | +18% | +15% | 8% | 19.8× | -6.7% | +9.2% |
| Suzhou MedicalSystem Technology 603990.SS | China | $1.04B | +44% | -15% | 5% | 95.1× | n/a | n/a |